ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Calcium"

  • Abstract Number: 2043 • 2018 ACR/ARHP Annual Meeting

    Monocytes and Macrophages of Patients with Rheumatoid Arthritis Respond to Pathologically Increased Ionized Calcium with Proinflammatory Cytokine Production

    Supriya Murthy1, Elisabeth Jaeger1, Sebastian Jung1, Kathleen Friedrich2, Olga Seifert1, Christoph Baerwald1, Matthias Pierer1 and Manuela Rossol1, 1Department of Internal Medicine, Rheumatology, University of Leipzig, Leipzig, Germany, 2Department of Internal Medicine, Rheumatology, University of Leipzig, Germany, Leipzig, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovitis and periarticular bone erosion. Bony erosions and cell necrosis might lead to a local…
  • Abstract Number: 1449 • 2016 ACR/ARHP Annual Meeting

    The Efficiency of the Regulation of Ca2+ Entry through Calcium Release-Activated Calcium Channel in the Treatment of Rheumatoid Arthritis

    Shuang Liu1, Hitoshi Hasegawa2, Takeshi Kiyoi3, Tatsuya Sawasaki4 and Kazutaka Maeyama5, 1Dept. Pharmacology,, Ehime University Graduate School of Medicine, Toon-shi, Japan, 2Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan, 3Bioscience, Integrated Center for Sciences, Ehime University, Ehime, Japan, 4Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan, 5Department of Pharmacology, Informational Biomedicine, Ehime University Graduate School of Medicine, Toon-shi, Ehime, Japan

    Background/Purpose:  The regulation of Ca2+ entry by targeting a store-operated calcium release-activated channel (CRAC), known as ORAI, has shown benefits in the treatment of rheumatoid…
  • Abstract Number: 2124 • 2016 ACR/ARHP Annual Meeting

    Maintenance of Chondrocyte Phenotypic Stability By TRPC6 Calcium Channel Activity

    Joanna Sherwood1, Jessica Bertrand2, Francesco Dell'Accio3 and Thomas Pap4, 1Institute for Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany, 2Department of Orthopedic Surgery, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany, 3William Harvey Research Institute,, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 4Institute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany

    Background/Purpose: The ELR+ CXC chemokine CXCL6 is produced by healthy articular chondrocytes and retained within the cartilage matrix via interactions with heparan sulphate proteoglycans. There,…
  • Abstract Number: 2557 • 2016 ACR/ARHP Annual Meeting

    Tumor Necrosis Factor (TNF) Sensitizes Rheumatoid Synovial Fibroblasts to TRPA1-Mediated Calcium Flux, Anti-Proliferation and Cell Death

    Torsten Lowin1, Rainer Straub2 and Georg Pongratz3, 1Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany, 2Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine, University Hospital Regensburg, Regensburg, Germany, 3Rheumatology - Hiller Research Center Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany

    Background/Purpose:  In rheumatoid arthritis (RA), synovial fibroblasts (SF) are one main contributor of joint destruction since they resist apoptosis and secrete pro-inflammatory cytokines and matrix…
  • Abstract Number: 379 • 2015 ACR/ARHP Annual Meeting

    Validation of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis

    Linda Rasch1, Marian de van der Schueren2, Lilian van Tuyl1, Irene Bultink1 and Willem Lems1, 1Amsterdam Rheumatology and immunology Center, location VU University Medical Center, Department of Rheumatology, Amsterdam, Netherlands, 2Department of Nutrition and Dietetics, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Calcium supplements are prescribed for prevention of osteoporotic fractures, but excess intake has been associated with cardiovascular events. The most adequate tools for estimating…
  • Abstract Number: 1148 • 2015 ACR/ARHP Annual Meeting

    The Role of TRPC6 in CXCR2-Mediated Chondrocyte Phenotypic Stability

    Joanna Sherwood1, Jessica Bertrand1, Francesco Dell'Accio2 and Thomas Pap3, 1Institute for Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany, 2EMR, Queen Mary's School of Medicine and Dentistry, London, United Kingdom, 3Institute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany

    Background/Purpose: We have recently demonstrated that ELR+ CXC chemokines signaling via the CXCR2 receptor, are produced by healthy chondrocytes and are retained within the cartilage…
  • Abstract Number: 2085 • 2015 ACR/ARHP Annual Meeting

    DC-STAMP Regulates Osteoclastogenesis through the Ca2+ /NFATc1 Axis

    Yahui Grace Chiu1, Dongge Li2, Yue-Xin Xu3, Tzong-Ren Sheu4, Minsoo Kim5 and Christopher T. Ritchlin6, 1Allergy, Immunology, and Rheumatology, University of Rochester, Rochester, NY, 2Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 3Microbiology & Immunology, University of Rochester, Rochester, NY, 4Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 5Microbiology and Immunology, University of Rochester, Rochester, NY, 6Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Osteoclasts (OC) are the only cell type known to erode bone. Many bone diseases including osteoporosis and arthritis are caused by excessive OC activity.…
  • Abstract Number: 2906 • 2014 ACR/ARHP Annual Meeting

    Systemic Delivery of Short Hairpin RNA Targeting Calcium Release-Activated Calcium Channel 3 Down-Regulates Severity of Collagen-Induced Arthritis

    Shuang Liu1, Takeshi Kiyoi2, Shohei Watanabe3 and Kazutaka Maeyama1, 1Department of Pharmacology, Informational Biomedicine, Ehime University Graduate School of Medicine, Toon-shi, Ehime, Japan, 2Bioscience, Integrated Center for Sciences, Ehime University, Ehime, Japan, 3Japan Community Health Care Organization Uwajima Hospital, Ehime, Japan

    Background/Purpose: In recent years, one widespread and potentially important Ca2+ channel, store-operated Ca2+-release-activated Ca2+ (CRAC) channel is raised in drug discovery for rheumatoid arthritis (RA).…
  • Abstract Number: 2794 • 2014 ACR/ARHP Annual Meeting

    Deletion of the Inhibitory Receptor Motif, ITIM, on DC-STAMP Alters Osteoclast Differentiation and Function

    Yahui Grace Chiu1, Edward M. Schwarz2, Dongge Li1, Yuexin Xu3, Minsoo Kim3 and Christopher T. Ritchlin4, 1Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 2Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 3Microbiology and Immunology, University of Rochester, Rochester, NY, 4Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY

    Background/Purpose DC-STAMP (Dendritic Cell-Specific Transmembrane Protein), a 7-pass transmembrane protein essential for cell-to-cell fusion during osteoclast (OC) differentiation, is expressed on the cell surface of…
  • Abstract Number: 2683 • 2014 ACR/ARHP Annual Meeting

    The Discovery of Novel Splicing Variants of Neurogranin and Their Role in the Pathogenesis of Systemic Lupus Erythematosus

    Xiaofang Luo1, Xuelan He1, Chaonan Wu1, Juan Ni1, Ling li Dong2 and Shouxin Li2, 1Department of Rheumatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    Background/Purpose Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease with a diverse array of clinical manifestations that is characterized by the production of antibodies…
  • Abstract Number: 1996 • 2014 ACR/ARHP Annual Meeting

    Improvement in Basic Bone Health Knowledge Among VA Primary Care Practitioners during a Focused Musculoskeletal Mini-Residency

    Mathilde Pioro1, Nancy Fisher1, Marissa Grotzke2, Grant W. Cannon3 and Michael Battistone4, 1Rheumatology, Cleveland Veterans Affairs Medical Center, Cleveland, OH, 2Salt Lake CIty Veterans Affairs Medical Center, Salt Lake CIty, UT, 3Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 4University of Utah Health Sciences Center, Salt Lake City, UT

    Background/Purpose: Osteopenia and osteoporosis are common yet underrecognized in the veteran population. Methods: We tested basic bone health related knowledge among Veterans Affairs (VA) primary…
  • Abstract Number: 1680 • 2014 ACR/ARHP Annual Meeting

    an Indirect Comparisons Analysis of Medications Used for Treatment of Raynaud’s Phenomenon

    Sampath Manickam1, Elie Donath2, Sandeep Dayanand3 and Jonathan Greer4, 1University of Miami Palm Beach Internal Medicine, West Palm Beach, FL, 2Internal Medicine, University of Miami Miller School of Medicine Palm Beach Regional Campus, Atlantis, FL, 3University of Miami Palm Beach Internal medicine, West palm beach, FL, 4Arthritis & Rheumatology Associates, Boynton Beach, FL

    An Indirect Comparisons Analysis of Medications used for treatment of Raynaud’s phenomenonBackground/Purpose: There are several pharmacological treatments used for treatment of Raynaud’s phenomenon: calcium channel…
  • Abstract Number: 1035 • 2014 ACR/ARHP Annual Meeting

    TNF-á Modulates the Expression of Circadian Clock Genes Via Calcium Signaling in Rheumatoid Synovial Cells

    Kohsuke Yoshida1, Nao Shibanuma2, Teppei Hashimoto3,4, Yoshiko Kawasaki4, Naonori Hashimoto1, Ayako Nakai1, Kenta Kaneshiro1, Koji Tateishi5, Natsuko Nakagawa5 and Akira Hashiramoto1,4,6, 1Faculty of Health Sciences, Kobe University School of Medicine, Kobe, Japan, 2Department of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 3Department of General Internal Medicine, Kobe University School of Medicine, Kobe, Japan, 4Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 5Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 6Clinical Immunology, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose: The mammalian clock genes including Clock (circadian locomotor output cycles kaput), Bmal1 (brain and muscle Arnt-like protein 1), Per (Period) and Cry (Cryptochrome) regulate…
  • Abstract Number: 136 • 2013 ACR/ARHP Annual Meeting

    The Detection Of Primary Hyperparathyroidism In Patients Diagnosed With Fibromyalgia

    Michael Tsoukas1, Peter A. Ste-Marie2, Yoram Shir2, Mary-Ann Fitzcharles3 and Elliot Mitmaker4, 1Endocrinology, McGill University Health Centre, Montreal, QC, Canada, 2Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 3Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 4General and Endocrine Surgery, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Some illnesses, such as hypothyroidism or small fiber neuropathy, may present similarly to fibromyalgia (FM), or may in turn lead to an augmented polysymptomatic…
  • Abstract Number: 1822 • 2013 ACR/ARHP Annual Meeting

    Oleanolic Acid Acetate Inhibits Osteoclast Differentiation By Downregulating Phospholipase Cγ2 –calcium ion oscillation-Nuclear Factor Of Activated T Cell c1 Signaling, and Suppresses Bone Loss In Mice

    Chang-Hoon Lee1, Myeung Su Lee1, Won Seok Lee2, Wan-Hee Yoo3, Ju-Young Kim4, Jae-Min Oh4 and Yong-Geun Jeong5, 1Department of Internal Medicine, School of Medicine, Wonkwang University, Iksan, Chonbuk, South Korea, 2Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 3Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 4Department of Anatomy, School of Medicine, Wonkwang University, Iksan, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Changwon Fatima Hospital, Changwon, South Korea

    Background/Purpose: we first isolated oleanolic acid acetate (OAA), a triterpenoid compound, from Vigna angularis(azuki bean) to discover anti-bone resorptive agents. Many studies have identified and…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology